Sources Sought Notice – Influenza A/B & COVID-19 Combination Testing
The Regional Health Contracting Office – Central is issuing this Sources Sought Notice on behalf of
San Antonio Military Medical Center, JBSA – Fort Sam Houston, Texas. Any responses to this Sources
Sought Notice will be used for planning purposes only. This notice is not a solicitation of binding
offers, nor is it a notice to proceed.
The San Antonio Military Medical Center (SAMMC) has a requirement for SARS-CoV-2 & Influenza A/B
Combo Nucleic Acid Test (and the SARS-CoV-2 & Influenza A/B Quality Control Kits) for FY22 through
Vendors that consider themselves capable of providing the required testing are invited to submit a
capability statement for the Government to consider via email to the Point of Contact listed
herein. This capability statement shall include the following information. If the capability
statement does not address ALL of the points below, the vendor will not be considered as capable of
providing the required testing:
1. Vendor name (to include CAGE code and DUNS number); Point of Contact (to include email address
and phone number); business size.
2. Documentation that demonstrates its ability to provide SARS-CoV-2 & Influenza A/B Combo
Nucleic Acid Test (and quality control kits) testing.
3. Food and Drug Administration (FDA) approval if applicable.
The SARS-CoV-2 & Influenza A/B Combo Nucleic Acid Test will allow the SAMMC to simultaneously
detect COVID-19 and Influenza A and B strains in patients. With the looming overlap of the
traditional influenza season and the ongoing COVID-19 pandemic, it is imperative that the
laboratory has the ability to perform this diagnostic function for the identification of the below items for patient treatment.
The response due date for this Sources Sought Notice is 12:00 PM CST, 10 September 2021.
All questions and comments regarding this announcement shall be submitted via e-mail to the below POCs:
See attached spreadsheet with the reagents & quantity included.